US
NSG 533 Adv Pharm: Module 1: GI: Chp 17 Exam 2025 Questions and Answers
NSG 533 Adv Pharm: Module 1: GI: Chp 17 Exam 2025 Questions and Answers
Course:
NSG 533
Institution:
NSG 533
NSG 533 Adv Pharm: Module 1: GI: Chp 17 Exam 2025 Questions and Answers
After purchase, you get:
✅ Instant PDF Download
✅ Verified answer explanations
✅ Refund if not Satisfied
✅ Prepared for 2025/2026 test cycle
Document Information
| Uploaded on: | September 4, 2025 |
| Last updated: | September 4, 2025 |
| Number of pages: | 10 |
| Written in: | 2025/2026 |
| Type: | Exam (elaborations) |
| Contains: | Questions & Answers |
| Tags: | NSG 533 Adv Pharm: Module 1: GI: Chp 17 Exam 2025 Questions and Answers |
Seller Information
SophiaBennett
Reviews Received
User Reviews (0)
Exam (Elaborations)
$9.50
Bundle Deal! Get all 15 docs for just $24.99
Add to Cart
100% satisfaction guarantee
Refund Upon dissatisfaction
Immediately available after purchase
Available in Both online and PDF
$9.50
| 0 sold
Discover More Resources
Available in a Bundle
Content Preview
NSG 533 Adv Pharm: Module 1: GI: Chp 17 Exam 2025 Questions and Answers Which drug class is most effective in treating erosive lesions:? - ....ANSWER ...- PPIs Name 4 H2RAs: - ....ANSWER ...-Cimetidine (Tagamet) Famotidine (Pepcid) Ranitidine (Zantac) Nizatidine (Axid) What is the action of H2RAs? - ....ANSWER ...-Decrease acid secretion by blocking histamine 2-receptors in gastric parietal cells Name 4 benefits of H2RAs - ....ANSWER ...-1. Relieve GERD symptoms 2. Can be administered prophylactically 3. More effective at controlling chronic GERD symptoms than ANTACIDS 4. Intermittent & routine dosing possible based on degree of symptom control needed. Name 2 drawbacks of H2RAs - ....ANSWER ...-1. Less effective in controlling chronic GERD symptoms than PPIs 2. Renal elimination may require dose adjustment in kidney dysfunction patients …FOR STUDENTS ONLY…©️2025 ALL RIGHTS RESERVED… 1
